P
Planet Fitness, Inc.
PLNT · Consumer Cyclical
Q4 FY2025
Earning ended Dec 31, 2025Report generated Mar 10, 2026
The Royalty Machine Nobody Sees Has a GLP-1 Problem
Most investors are debating gym saturation and pricing power; the second-order question they're not asking is whether Ozempic quietly obsoletes the demand thesis for a brand built entirely around helping people who want to lose weight show up to try. The business model upgrade is real and underappreciated — the risk to what that model sells is equally real and underappreciated.
Flowly Score
Apr 16 Close
+1%$71.46
Fair Value
$72.00
52
Averageat $71.46
Business Strength7/10
The quiet transformation into a near-pure royalty-and-equipment tollbooth is a genuine upgrade — ROIC climbing to 14% confirms the franchise model is compounding, not just recovering. The counter-positioning moat is real but shallow: no switching costs means inertia, not loyalty, is doing most of the retention work.
Financial Resilience6/10
OCF running nearly double net income is a clean signal of earnings quality, and the Piotroski 8/9 reflects a fundamentally sound operating business. But the Altman Z-Score at 1.65 is a flashing yellow light — the whole-business securitization structure means the balance sheet is more fragile than the asset-light franchise narrative implies.
Growth & Trajectory6/10
Record club openings and double-digit member growth are real, but management just flagged 2026 as the weakest year in their stated algorithm — a signal that the easy domestic runway is behind them, not ahead. International is barely a rounding error after years of existence, which either means there's optionality no one is pricing or there are structural reasons the model doesn't travel.
Valuation5/10at $77.89
The current price embeds the optimistic scenario as base case — you're paying for roughly 18% annual FCF growth from a maturing domestic franchisor, which is a top-decile ask for a business with a visible domestic ceiling. The P/E compression from stratospheric COVID-era multiples flatters the current price optically, but the neutral DCF sits meaningfully below where the stock trades today.
Risk4/10
GLP-1 drugs are not abstract downside — they target Planet Fitness's exact core member: overweight, motivated to try but not a gym identity, looking for permission to start. If weight loss becomes pharmaceutical rather than behavioral, the demand driver behind the judgment-free concept erodes at its root, and no amount of cold plunge amenities patches that structural hole.
Planet Fitness just completed one of the quietest business model transformations in consumer franchise history: it shed capital-intensive corporate stores and emerged as a near-pure royalty and captive equipment machine. The ROIC improvement tells you this wasn't cosmetic — the underlying economics genuinely got better. But the current price demands that this upgraded model sustains top-decile growth for years, which is a significant ask for a business whose domestic unit count is approaching the natural ceiling of strip-mall America. The franchise flywheel is intact, but you're paying a premium for it with almost no margin of safety built in. The trajectory from here depends on two variables in tension: pricing power and demand durability. Management has real pricing runway — the headline membership price hasn't moved meaningfully in decades, and the Black Card penetration at record highs proves members will pay more when the value proposition is clear. A successful mid-tier price restructuring could re-rate FCF without a single new club opening. But the 2026 guidance disappointment, framed as transitory, is worth watching closely — management teams that guide below their own stated three-year algorithm in year one of that algorithm have a pattern worth noting. The single biggest risk isn't competition or real estate saturation — it's GLP-1 drugs reshaping the behavior of Planet Fitness's core demographic. The judgment-free positioning exists precisely because it serves people who are self-conscious about their bodies and overwhelmed by fitness culture. That psychological profile is the highest-probability GLP-1 adopter. If pharmaceutical weight loss reduces the pool of new members who find the judgment-free framing compelling, net member additions slow structurally rather than cyclically — and the franchise royalty growth story unravels from its demand foundation, not its supply side.